Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same

A compound with the following formula (I):

• or formula (II):
• wherein
• AH represents —CO2H, —SO3H or —PO3H2;
• l is 1, 2 or 3;
• m and n are independently 0, 1 or 2;
• R3 and R4 represent independently a hydrogen atom, a hydroxy group, a halogen atom, an alkyl or a haloalkyl group;
• the ring (depicted by a circle in each formula) represents an aryl or a heterocycle;
• with R1 and R2 representing independently a hydrogen atom, a halogen atom, a cyano group, an alkyl group, an alkoxy group, an alkylthio group, an alkylsulfoxide group, an alkylsulfonyl group, a haloalkyl group, a haloalkoxy group, a haloalkylthio group, an acyl group, an O-cycloalkyl group, a heteroalkyl group, an O-aryl group, an O-arylalkyl group, an aryl group, a heterocycle group or an arylalkyl group;
• and
• a pharmaceutical salt, solvate, zwitterionic form or prodrug thereof.